United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE288.0600
- TODAY'S CHANGE (%)0.4700 (0.1634%)
- Bid / Lots222.5000/ 1
- Ask / Lots319.9400/ 2
- Open / Previous Close285.8300 / 287.5900
- Day Range
- 52 Week Range
- Volume406,565
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 2999 | 285.83 |
| 09:36 ET | 200 | 285.72 |
| 09:41 ET | 363 | 286.25 |
| 09:43 ET | 100 | 286.25 |
| 09:45 ET | 1005 | 286.3 |
| 09:48 ET | 200 | 285.98 |
| 09:52 ET | 1235 | 286.42 |
| 09:54 ET | 1500 | 287.035 |
| 09:56 ET | 1388 | 286.53 |
| 10:01 ET | 186 | 285.98 |
| 10:03 ET | 100 | 286.59 |
| 10:08 ET | 5035 | 286.205 |
| 10:10 ET | 600 | 286.52 |
| 10:12 ET | 107 | 286.245 |
| 10:14 ET | 1000 | 286.225 |
| 10:15 ET | 800 | 286.25 |
| 10:17 ET | 478 | 286.235 |
| 10:21 ET | 1100 | 286.54 |
| 10:24 ET | 100 | 286.27 |
| 10:26 ET | 600 | 286.24 |
| 10:28 ET | 2200 | 286.25 |
| 10:30 ET | 600 | 286.25 |
| 10:32 ET | 400 | 286.25 |
| 10:33 ET | 500 | 286.5 |
| 10:35 ET | 1281 | 286.49 |
| 10:37 ET | 100 | 286.9 |
| 10:39 ET | 200 | 286.75 |
| 10:42 ET | 604 | 287.285 |
| 10:44 ET | 100 | 287.46 |
| 10:46 ET | 1242 | 287.52 |
| 10:48 ET | 700 | 288.07 |
| 10:50 ET | 177 | 288 |
| 10:51 ET | 100 | 287.87 |
| 10:55 ET | 100 | 287.745 |
| 10:57 ET | 1703 | 287.855 |
| 11:02 ET | 2680 | 287.93 |
| 11:04 ET | 100 | 287.92 |
| 11:08 ET | 3840 | 287.15 |
| 11:09 ET | 600 | 286.16 |
| 11:11 ET | 100 | 286.4835 |
| 11:15 ET | 300 | 286.315 |
| 11:22 ET | 400 | 286.26 |
| 11:26 ET | 425 | 286.47 |
| 11:29 ET | 1117 | 286.54 |
| 11:31 ET | 615 | 286.74 |
| 11:40 ET | 300 | 286.62 |
| 11:42 ET | 4179 | 287.05 |
| 11:44 ET | 100 | 286.989 |
| 11:45 ET | 500 | 286.93 |
| 11:54 ET | 600 | 286.953 |
| 11:56 ET | 1100 | 286.83 |
| 11:58 ET | 805 | 287.01 |
| 12:00 ET | 1217 | 287.35 |
| 12:02 ET | 200 | 287.36 |
| 12:03 ET | 100 | 287.24 |
| 12:05 ET | 100 | 287.25 |
| 12:12 ET | 1300 | 287.43 |
| 12:14 ET | 1600 | 287.52 |
| 12:16 ET | 1000 | 287.175 |
| 12:23 ET | 100 | 287.19 |
| 12:27 ET | 940 | 287.4 |
| 12:38 ET | 100 | 287.27 |
| 12:41 ET | 600 | 287.55 |
| 12:48 ET | 1800 | 287.635 |
| 12:50 ET | 700 | 287.63 |
| 12:54 ET | 6287 | 287.565 |
| 12:56 ET | 1402 | 286.935 |
| 12:59 ET | 300 | 287.21 |
| 01:03 ET | 161 | 286.83 |
| 01:08 ET | 100 | 287.07 |
| 01:14 ET | 200 | 287.165 |
| 01:15 ET | 200 | 287.293 |
| 01:17 ET | 430 | 287.075 |
| 01:19 ET | 100 | 287.115 |
| 01:24 ET | 1017 | 286.9 |
| 01:26 ET | 1211 | 286.965 |
| 01:30 ET | 100 | 286.97 |
| 01:33 ET | 1756 | 286.59 |
| 01:35 ET | 136 | 286.84 |
| 01:37 ET | 102 | 286.615 |
| 01:42 ET | 100 | 286.61 |
| 01:44 ET | 1600 | 286.79 |
| 01:46 ET | 400 | 286.87 |
| 01:48 ET | 300 | 287.15 |
| 01:51 ET | 100 | 287.02 |
| 01:53 ET | 1367 | 286.915 |
| 01:55 ET | 100 | 286.91 |
| 01:57 ET | 364 | 286.895 |
| 02:00 ET | 179 | 286.78 |
| 02:02 ET | 1614 | 286.64 |
| 02:04 ET | 300 | 286.58 |
| 02:06 ET | 239 | 286.43 |
| 02:09 ET | 114 | 286.64 |
| 02:13 ET | 813 | 286.8 |
| 02:20 ET | 176 | 286.84 |
| 02:22 ET | 100 | 286.855 |
| 02:26 ET | 1329 | 287.04 |
| 02:27 ET | 200 | 287.37 |
| 02:29 ET | 800 | 287.24 |
| 02:31 ET | 200 | 287.422 |
| 02:38 ET | 400 | 287.37 |
| 02:40 ET | 104 | 287.285 |
| 02:44 ET | 738 | 287.41 |
| 02:45 ET | 600 | 287.61 |
| 02:47 ET | 947 | 287.46 |
| 02:49 ET | 176 | 287.52 |
| 02:51 ET | 1955 | 287.58 |
| 02:54 ET | 3630 | 287.445 |
| 03:00 ET | 200 | 287.69 |
| 03:02 ET | 300 | 287.54 |
| 03:03 ET | 1504 | 287.69 |
| 03:07 ET | 100 | 287.74 |
| 03:12 ET | 562 | 287.895 |
| 03:14 ET | 3100 | 287.905 |
| 03:16 ET | 730 | 287.79 |
| 03:18 ET | 500 | 287.91 |
| 03:20 ET | 449 | 287.875 |
| 03:21 ET | 200 | 287.65 |
| 03:23 ET | 661 | 287.66 |
| 03:25 ET | 275 | 287.51 |
| 03:27 ET | 901 | 287.4 |
| 03:32 ET | 1246 | 287.58 |
| 03:36 ET | 2465 | 287.915 |
| 03:38 ET | 200 | 287.995 |
| 03:39 ET | 200 | 288.11 |
| 03:41 ET | 4181 | 288.2975 |
| 03:43 ET | 836 | 288.36 |
| 03:45 ET | 800 | 288.485 |
| 03:48 ET | 1500 | 288.645 |
| 03:50 ET | 5004 | 288.33 |
| 03:52 ET | 1900 | 287.9 |
| 03:54 ET | 3006 | 287.75 |
| 03:56 ET | 3940 | 287.97 |
| 03:57 ET | 4644 | 287.94 |
| 03:59 ET | 9301 | 288.06 |
Jun 12, 2024
DJ United Therapeutics Is Maintained at Overweight by Wells Fargo, from 8:37AM ET on Wednesday Jun 12, 2024 by Dow Jones
8:37AM ET on Wednesday Jun 12, 2024 by Dow Jones
Jun 5, 2024
United Therapeutics Corporation to Present at the Goldman Sachs 45(th) Annual Global Healthcare Conference, from 7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
Jun 3, 2024
*DJ Liquidia District Court Issues Favorable Ruling and Denies United Therapeutics' Request to Block Yutrepia Launch >LQDA, from 7:03AM ET on Monday Jun 03, 2024 by Dow Jones
7:03AM ET on Monday Jun 03, 2024 by Dow Jones
May 21, 2024
DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones
12:23PM ET on Tuesday May 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 12.8B | 13.6x | +8.22% |
Medpace Holdings Inc | 12.2B | 40.1x | +35.10% |
Biomarin Pharmaceutical Inc | 15.9B | 79.0x | --- |
Neurocrine Biosciences Inc | 13.6B | 37.2x | +62.04% |
Qiagen NV | 9.4B | 27.8x | +12.66% |
Beigene Ltd | 17.9B | -21.5x | --- |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.8B |
|---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.54 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 13.6x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | 11.6x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
